A Phase III, Randomized, Double-Blind, Placebo-controlle

Project: Research project

Project Details

Description

A Phase III, Randomized, Double-Blind, Placebo-controlled Study at Assess the Efficacy and Safety of 10mg ZD4054 in Combination with Docataxel in comparison with Docetaxel in Patients with Metastatic Hormone- resistant Prostate Cancer
StatusFinished
Effective start/end date7/1/0912/31/11

Funding

  • AstraZeneca

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.